Mark L. Levitt
Medical Director
Oncology
Redhill Biopharma
Israel
Biography
Dr. Levitt is a Board Certified Medical Oncologist and Internist in the US and is Specialty Certified as an Oncologist (Medical and Radiation) and Internist in Israel. Prior to joining RedHill, Dr. Levitt served as Head of the Oncology Therapeutic Area, Global Business Development. Dr. Levitt also previously served as Head of the Lung Cancer Unit at Sheba Medical Center and held positions at Inotek Pharmaceuticals and in leading US universities. Dr. Levitt completed his internship and residency in Internal Medicine at Hahnemann University Hospital and his fellowship in Medical Oncology at the National Cancer Institute (NIH). Dr. Levitt is a Board Certified Medical Oncologist and Internist in the US and is Specialty Certified as an Oncologist (Medical and Radiation) and Internist in Israel. Prior to joining RedHill, Dr. Levitt served as Head of the Oncology Therapeutic Area, Global Business Development. Dr. Levitt also previously served as Head of the Lung Cancer Unit at Sheba Medical Center and held positions at Inotek Pharmaceuticals and in leading US universities. Dr. Levitt completed his internship and residency in Internal Medicine at Hahnemann University Hospital and his fellowship in Medical Oncology at the National Cancer Institute (NIH).
Research Interest
Oncology
